Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.
Saved in:
| Title: | Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial. |
|---|---|
| Authors: | Alsaleh, K.1 (AUTHOR) khalid_alsaleh@hotmail.com, Al Zahwahry, H.2 (AUTHOR), Bounedjar, A.3 (AUTHOR), Oukkal, M.4 (AUTHOR), Saadeddine, A.5 (AUTHOR), Mahfouf, H.6 (AUTHOR), Bouzid, K.7 (AUTHOR), Bensalem, A.8 (AUTHOR), Filali, T.9 (AUTHOR), Abdel-Razeq, H.10 (AUTHOR), Larbaoui, B.11 (AUTHOR), Kandil, A.12 (AUTHOR), Abulkhair, O.13 (AUTHOR), Al Foheidi, M.14 (AUTHOR), Ghosn, M.15 (AUTHOR), Rasool, H.16 (AUTHOR), Boussen, H.17 (AUTHOR), Mezlini, A.18 (AUTHOR), Haddaoui, A.18 (AUTHOR), Ayari, J.19 (AUTHOR) |
| Source: | Journal of Cancer Research & Clinical Oncology. Aug2023, Vol. 149 Issue 9, p6171-6179. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
